Melatoninergic system in Parkinson’s disease: from neuroprotection to the management of motor and nonmotor symptoms (2016)
- Authors:
- Mack, Josiel Mileno - Universidade Federal de Santa Catarina (UFSC)
- Schamne, Marissa Giovanna - Universidade Federal de Santa Catarina (UFSC)
- Sampaio, Tuane Bazanella - Universidade Federal de Santa Catarina (UFSC)
- Pértile, Renata Aparecida Nedel
- Fernandes, Pedro Augusto Carlos Magno
- Markus, Regina P
- Prediger, Rui Daniel - Universidade Federal de Santa Catarina (UFSC)
- USP affiliated authors: FERNANDES, PEDRO AUGUSTO CARLOS MAGNO - IB ; MARKUS, REGINA PEKELMANN - IB
- Unidade: IB
- DOI: 10.1155/2016/3472032
- Subjects: DOENÇA DE PARKINSON; MELATONINA; DOENÇAS NEURODEGENERATIVAS; AGENTES DOPAMINÉRGICOS; ANTIOXIDANTES; NEUROCIÊNCIAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Oxidative Medicine and Cellular Longevity
- ISSN: 1942-0994
- Volume/Número/Paginação/Ano: v. 2016, p. 1-31, art. ID 3472032, 2016
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by
-
ABNT
MACK, Josiel Mileno et al. Melatoninergic system in Parkinson’s disease: from neuroprotection to the management of motor and nonmotor symptoms. Oxidative Medicine and Cellular Longevity, v. 2016, p. 1-31, 2016Tradução . . Disponível em: https://doi.org/10.1155/2016/3472032. Acesso em: 28 dez. 2025. -
APA
Mack, J. M., Schamne, M. G., Sampaio, T. B., Pértile, R. A. N., Fernandes, P. A. C. M., Markus, R. P., & Prediger, R. D. (2016). Melatoninergic system in Parkinson’s disease: from neuroprotection to the management of motor and nonmotor symptoms. Oxidative Medicine and Cellular Longevity, 2016, 1-31. doi:10.1155/2016/3472032 -
NLM
Mack JM, Schamne MG, Sampaio TB, Pértile RAN, Fernandes PACM, Markus RP, Prediger RD. Melatoninergic system in Parkinson’s disease: from neuroprotection to the management of motor and nonmotor symptoms [Internet]. Oxidative Medicine and Cellular Longevity. 2016 ; 2016 1-31.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1155/2016/3472032 -
Vancouver
Mack JM, Schamne MG, Sampaio TB, Pértile RAN, Fernandes PACM, Markus RP, Prediger RD. Melatoninergic system in Parkinson’s disease: from neuroprotection to the management of motor and nonmotor symptoms [Internet]. Oxidative Medicine and Cellular Longevity. 2016 ; 2016 1-31.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1155/2016/3472032 - Long-lasting priming of endothelial cells by plasma melatonin levels
- Effects of acute hypothyroidism on plasma melatonin and Aanat and Asmt expression in the pineal gland and gonads of rats
- The Concept of the Immune-Pineal Axis Tested in Patients Undergoing an Abdominal Hysterectomy
- Melatonin and inflammation: the role of the immune-pineal axis and sympathetic tonus
- Amyloid b peptide directly impairs pineal gland melatonin synthesis and melatonin receptor signaling through the ERK pathway
- Daily rhythm of salivary IL-1ß, cortisol and melatonin in day and night workers
- Daily variation of constitutively activated nuclear factor kappa B (NFKB) in rat pineal gland
- TLR4 and CD14 receptors expressed in rat pineal gland trigger NFKB pathway
- Molecular basis for defining the pineal gland and pinealocytes as targets for tumor necrosis factor
- Endothelial cell adhesiveness is a function of environmental lighting and melatonin level
Informações sobre o DOI: 10.1155/2016/3472032 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
